Landec Corporation Sets Third Quarter Fiscal Year 2016 Conference Call for March 30, 2016 at 8 a.m. PT and Earnings Release Set for March 29, 2016 After Market

MENLO PARK, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Landec Corporation LNDC will hold a conference call on Wednesday, March 30, 2016 at 8 a.m. Pacific time to discuss its results for the third quarter fiscal 2016. Financial results will be reported for the 2016 fiscal third quarter ended February 28, 2016 after market close on March 29, 2016.

Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.

Date: Wednesday, March 30, 2016
Time: 8 a.m. Pacific time (11 a.m. Eastern time)  
Toll Free Participant Dial-in Number: (866) 814-1914
U.S. and International Toll Number: (703) 639-1358
Conference ID: 1670124

Webcast:  www.Landec.com/earningscall
The webcast will be available for 30 days through April 29, 2016.

A replay of the teleconference will be available for one week until midnight Eastern Time, Wednesday, April 6, 2016.

Toll free replay dial in: 888-266-2081
International replay:  703-925-2533 
Replay passcode: 1670124

About Landec Corporation

Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets.  Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the company, visit Landec's website at www.landec.com.